-The Indian Express New Delhi: Vegetables are the noble folk of food world, loved equally by doctors and grandmothers. Vegetarians live off them and meat-eaters are told to live off them. But in Delhi, under every crunchy leaf of radish or the shiny brinjal hide dangerous amounts of pesticides that can slowly kill, shows a new study by JNU. Pritha Chatterjee and Aniruddha Ghosal report how growers, consumers and the authorities may...
More »SEARCH RESULT
Total Matching Records found : 835
Wither Away the Pressure on India's Patent Law -Saradindu Bhaduri
-Vikalp Once again, India is under pressure from the US to revise its patent law. Anyone familiar with the activities of the United States Trade Representatives (USTR) would know that this is nothing new. It has been among the USTR's primary mandates to use trade restrictions in order to persuade (to put it mildly) countries to strengthen their IPR laws. There is, however, a qualitative difference between the actions it has...
More »High uranium content found in Punjab soil -Tomojit Basu
-The Hindu Business Line BARC finds 91.77 ppm of the material in DAP; fertiliser industry says it can't be blamed When the Bhabha Atomic Research Centre (BARC) found high levels of uranium in fertiliser and soil samples from the Malwa region of Punjab last week, activists in the area were not surprised. They have long been warning about environmental contamination due to excessive phosphate fertiliser use. Local reports indicated that BARC found uranium...
More »Generic drug makers get a boost from SC ruling -Ramnath Subbu
-The Hindu In a significant development for the pharmaceutical industry, the Supreme Court has rejected multinational Bayer's appeal to block production and sales of the low cost version of its kidney Cancer drug, sorafenib tosylate (branded as Nexavar), by Natco Pharmaceuticals. Hyderabad-based Natco was granted the first and to date only compulsory licence (CL) by the government in 2012 to make and sell a patented drug at a fraction of the...
More »52 more drugs brought under price ceiling
-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating Cancer and skin...
More »
